Equity Analysis

Company Profile

Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets

Company News

Shukra Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524632

INE551C01028

10.1085326

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

27.42

507.81

EPS(TTM)

Face Value()

Div & Yield %:

4.23

0.04

Back

Kabra Commercial standalone net profit rises 124.32% in the September 2023 quarter

Nov 09,2023

Net profit of Kabra Commercial rose 124.32% to Rs 0.83 crore in the quarter ended September 2023 as against Rs 0.37 crore during the previous quarter ended September 2022. Sales rose 9.97% to Rs 4.30 crore in the quarter ended September 2023 as against Rs 3.91 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	4.30	3.91	10
OPM %	10.00	10.74	-
PBDT	0.94	0.38	147
PBT	0.93	0.37	151
NP	0.83	0.37	124